CFDB - Cystic Fibrosis DataBase

  1. Home
  2. Database
Search (?)
at least one term
all terms
Advanced search
ongoing trials trial from www.clinicaltrials.gov

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis - Phase 1|Phase 2 - Not yet recruiting

  • Year: 2018
  • Date: January 2018
  • Author: Translate Bio, Inc.
Source

https://ClinicalTrials.gov/show/NCT03375047

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment

Participants

Cystic Fibrosis - 18 Years and older   (Adult, Senior)

Interventions

Drug: MRT5005|Drug: Normal saline

Outcome measures

Types, frequency and severity of treatment-emergent Adverse Events|Delivery of mRNA

Keywords: Adult; Adolescent; CFTR Modulators; Genetic Predisposition to Disease; pharmacological_intervention; MRT5005;